Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 07/18/2025 | CALL | $5.00 | 305 | +30 | +10.91% |
| 08/15/2025 | CALL | $5.00 | 13 | +5 | +62.50% |
| 01/16/2026 | CALL | $3.50 | 71 | +3 | +4.41% |
| 09/19/2025 | CALL | $7.50 | 114 | +2 | +1.79% |
| 07/18/2025 | CALL | $7.50 | 7 | 0 | |
| 07/18/2025 | PUT | $2.50 | 4 | 0 | |
| 01/16/2026 | PUT | $12.50 | 0 | 0 | |
| 01/16/2026 | PUT | $15.00 | 0 | 0 | |
| 01/16/2026 | PUT | $17.50 | 0 | 0 | |
| 01/16/2026 | PUT | $20.00 | 0 | 0 | |
| 07/18/2025 | CALL | $2.50 | 13 | -2 | -13.33% |
| 09/19/2025 | CALL | $5.00 | 182 | -31 | -14.55% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.87% | 980.49k | 7.16M |
| Federated Hermes MDT Small Cap Core Fund | 1.51% | 792.28k | 5.78M |
| iShares Russell 2000 ETF | 1.37% | 717.67k | 5.24M |
| BlackRock Advantage Small Cap Core Fund | 0.90% | 471.78k | 3.44M |
| Vanguard Extended Market Index Fund | 0.89% | 463.98k | 3.39M |
| iShares NASDAQ Biotechnology ETF | 0.75% | 394k | 2.88M |
| iShares Russell 2000 Value ETF | 0.63% | 330.18k | 2.41M |
| Price (T.Rowe) Health Sciences Fund | 0.59% | 311.26k | 2.27M |
| Lincoln VIP Tr-SSgA Small Mid Cap 200 Fund | 0.57% | 299.97k | 2.19M |
| Fidelity Small Cap Index Fund | 0.52% | 273.62k | 2M |
Diabetic Retinopathy Global Clinical Trials Review 2024: Region, country (G7 & E7), phase, trial status, End-points Status and Sponsor Type
01/10 10:35 am
GlobeNewswire Inc.
Read moreShould You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
06/20 08:23 am
Zacks Investment Research
Read moreWhy Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
06/14 11:30 am
Zacks Investment Research
Read moreKodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
05/16 12:51 pm
Zacks Investment Research
Read moreKodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
04/04 12:09 pm
Zacks Investment Research
Read moreKodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus
04/01 12:00 pm
Zacks Investment Research
Read moreTake the Zacks Approach to Beat the Market: NVIDIA, Dell, Modine in Focus
04/01 08:03 am
Zacks Investment Research
Read moreUS Stocks Flat; Initial Jobless Claims Fall To 210,000
03/28 10:32 am
Benzinga
Read moreMerck (MRK) Unit to Buy Elanco's Aqua Business for $1.3B
02/06 11:49 am
Zacks Investment Research
Read moreVertex's (VRTX) Q4 Earnings and Sales Surpass Estimates
02/06 11:26 am
Zacks Investment Research
Read moreTEVA Q4 Earnings and Revenues Surpass Estimates, Stock Up
02/01 12:51 pm
Zacks Investment Research
Read moreBiogen (BIIB) to Stop Selling Alzheimer's Disease Drug Aduhelm
02/01 11:27 am
Zacks Investment Research
Read moreDr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates
02/01 10:03 am
Zacks Investment Research
Read moreKodiak Sciences Inc. (KOD) Up 43.6% Since Last Earnings Report: Can It Continue?
12/14 12:30 pm
Zacks Investment Research
Read moreEyePoint (EYPT) Surges 178% on Upbeat Phase II Eye Disease Data
12/05 10:18 am
Zacks Investment Research
Read moreKodiak (KOD) Beats Q3 Earnings, Provides Pipeline Updates
11/15 09:00 am
Zacks Investment Research
Read moreDow Jones secures longest win streak since late July following best week of 2023
11/06 05:36 pm
MarketWatch
Read moreKodiak Sciences Inc. (KOD) Down 19.9% Since Last Earnings Report: Can It Rebound?
09/13 11:30 am
Zacks Investment Research
Read moreKodiak (KOD) Q2 Earnings Miss, New Lead Candidate in Focus
08/16 10:26 am
Zacks Investment Research
Read moreShould You Buy Kodiak Sciences (KOD) Ahead of Earnings?
08/14 08:34 am
Zacks Investment Research
Read more3 Biotech Stocks Poised to Beat Q2 Earnings Estimates
08/14 07:15 am
Zacks Investment Research
Read moreLigand (LGND) to Post Q2 Earnings: What's in Store?
08/07 09:02 am
Zacks Investment Research
Read moreEli Lilly (LLY) to Report Q2 Earnings: What's in the Cards?
08/02 10:09 am
Zacks Investment Research
Read moreExpert Ratings for Kodiak Sciences
07/27 05:00 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
07/27 11:00 am
Benzinga
Read moreBiotech Stock Roundup: BIIB, GSK's Q2 Earnings, KOD Faces Setback & More
07/26 10:08 am
Zacks Investment Research
Read moreKodiak Sciences Faces Downgrade Following Failed GLEAM And GLIMMER Studies
07/25 03:46 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
07/25 11:00 am
Benzinga
Read moreKodiak (KOD) Down as Late-Stage DME Studies Fail
07/25 09:16 am
Zacks Investment Research
Read moreCrude Oil Rises Over 2%; US Composite PMI Falls In July
07/24 12:43 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
07/24 11:00 am
Benzinga
Read moreDow Surges 150 Points; Domino's Pizza Earnings Top Expectations
07/24 10:45 am
Benzinga
Read moreWhy Is Kodiak Sciences Inc. (KOD) Up 62.9% Since Last Earnings Report?
06/14 11:30 am
Zacks Investment Research
Read moreZscaler, MongoDB, Chemours And Other Big Stocks Moving Higher On Friday
06/02 11:02 am
Benzinga
Read moreKodiak (KOD) Advances With Tarcocimab Amid Stiff Competition
05/30 11:14 am
Zacks Investment Research
Read moreVectivBio Holding, Greenhill, Atea Pharmaceuticals And Other Big Stocks Moving Higher On Monday
05/22 10:31 am
Benzinga
Read moreKodiak's (KOD) Q1 Earnings Miss, Pipeline in Focus, Stock Up
05/16 07:44 am
Zacks Investment Research
Read moreWhy Is Kodiak Sciences Inc. (KOD) Down 26.3% Since Last Earnings Report?
04/27 11:30 am
Zacks Investment Research
Read moreImmunic's (IMUX) Ulcerative Colitis Study Shows Positive Data
04/06 02:10 pm
Zacks Investment Research
Read morePalisade (PALI) Enrolls First Patient in LB1148 Study in China
04/06 02:09 pm
Zacks Investment Research
Read moreInflaRx (IFRX) Stock Up on FDA's EUA for COVID-19 Treatment
04/05 10:49 am
Zacks Investment Research
Read more